Viewing Study NCT05931393


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2025-12-25 @ 11:37 PM
Study NCT ID: NCT05931393
Status: RECRUITING
Last Update Posted: 2025-10-10
First Post: 2023-06-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)
Sponsor: University of Texas Southwestern Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module